Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of HCT116 cells subjected to low glucose or depleted of MAPKAPK2 expression.

ABSTRACT: MAPKAPK2, a component of p38 signaling pathway, is upregulated in colorectal cancer (CRC) and is known to regulate glucose metabolism. Utilizing HCT116, a CRC cell line, we identified that cancer cells can withstand low glucose conditions via upregulation of stress-induced survival pathways and downregulation of DNA metabolism and cell cycle related genes. As p38/MAPKAPK2 signaling is a well-known stress activated pathway, understanding the role played by this pathway in glucose-deprivation conditions was of particular interest. Interestingly, MAPKAPK2 levels decline in low glucose. We observed that MAPKAPK2 depletion results in upregulation or downregulation of pathways similar to glucose deprivation. Our findings suggest that MAPKAPK2 abundance plays critical role in proliferation versus survival depending on glucose availability.

ORGANISM(S): Homo sapiens

PROVIDER: GSE291324 | GEO | 2026/02/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Metabolic stress induces gene reprograming in ALL cells [RNA-seq]

Project description:To identify genes transcriptionally regulated under energy/metabolic stress, we treated CCRF-CEM/HA-AMPKa2 cells with Glucose deprivation condition for 24 hours, and examined their RNA profile using RNA-Seq. More than 3000 genes was altered (Fold Change > 1.5 or < -1.5, q value < 0.05) under energy/metabolic stress (glucose deprivation) vs. control, with approximately 60-70% genes exhibiting downregulation, whereas the remainder show upregulation. Note: sample headers in data_matrix_ctrl_no_glucose.txt, CTRL_7: Ctrl rep1 sample count number; CTRL_8: Ctrl rep2 count number; ONG_9: No glucose rep1 count number; ONG_10: No glucose rep2 count number;

2023-12-06 | GSE210212 | GEO

Oxidative stress, altered glucose metabolism and inflammation contribute to the retinal phenotype in the choroideremia zebrafish

Project description:Reactive oxygen species (ROS) within the retina play a key role in maintaining function and cell survival. However, excessive ROS can lead to oxidative stress, inducing dysregulation of metabolic and inflammatory pathways. The chmru848 zebrafish models choroideremia (CHM), an X-linked chorioretinal dystrophy which predominantly affects the photoreceptors, retinal pigment epithelium (RPE) and choroid. In this study, we examined the transcriptomic signature of the chmru848 zebrafish retina to reveal upregulation of cytokine pathways and glia migration, upregulation of oxidative, ER stress and apoptosis markers, and dysregulation of glucose metabolism with downregulation of glycolysis and upregulation of the oxidative phase of the pentose phosphate pathway. Glucose uptake was overall impaired in the chmru848 retina using the 2-NBDG glucose uptake assay, but after overexpression of human PFKM, it partially rescued the retinal phenotype and glucose uptake, but without modifying the expression of glycolysis markers. Therapies targeting glucose metabolism in CHM may represent a potential remedial approach.

2025-01-02 | GSE254948 | GEO

Early response evaluation by single cell signaling profiling in acute myeloid leukemia

Project description:Aberrant pro-survival signaling is a hallmark of cancer cells, but the response to chemotherapy is poorly understood. In this study, we investigate the initial signaling response to standard induction chemotherapy in a cohort of 32 acute myeloid leukemia (AML) patients, using 36-dimensional mass cytometry. Through supervised and unsupervised machine learning approaches, we find that reduction of extracellular-signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (MAPK) phosphorylation in the myeloid cell compartment 24h post-chemotherapy is a significant predictor of patient 5-year overall survival in this cohort. Validation by RNA sequencing show induction of MAPK target gene expression in patients with high phospho-ERK1/2 24h post-chemotherapy, while proteomics confirms an increase of the p38 prime target MAPK activated protein kinase 2 (MAPKAPK2). In this study, we demonstrate that mass cytometry can be a valuable tool for early response evaluation in AML and elucidate the potential of functional signaling analyses in precision oncology diagnostics.

2022-12-02 | GSE218664 | GEO

Role of 4EBP1/2 in the response to glucose deprivation

Project description:We investigated the function of the mTORC1 substrates and mRNA translation regulators 4EBP1/2 in the response to glucose deprivation. We uncovered that targeting 4EBP1/2 expression had a direct impact on the survival rates of cells challenged with glucose deprivation. To further define the mechanisms underlying 4EBP1/2 function under glucose deprivation, we conducted a proteomics analysis of HEK293 shRNA control and HEK293 shRNA 4EBP1/2 grown in basal media or under glucose deprivation (1 mM glucose containing media) for 30 hours.

2024-03-28 | PXD040931 | Pride

α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer [RNA-seq III]

Project description:Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumourigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC mutant intestinal organoids to promote stemness and leads to adenocarcinoma formation in vivo via decreasing intracellular alpha-ketoglutarate (aKG) levels. aKG supplementation is sufficient to rescue low-glutamine induced stemness and Wnt hyperactivation. Mechanistically, we found that aKG promotes hypomethylation of DNA and histone H3K4me3, leading to an upregulation of differentiation-associated genes and downregulation of Wnt target genes, respectively. Using CRC patient-derived organoids and several in vivo CRC tumour models, we show that aKG supplementation suppresses Wnt signaling and promotes cellular differentiation, thereby significantly restricting tumour growth and extending survival. Together, our results reveal how the low glutamine metabolic microenvironment impacts Wnt signaling and identify aKG as a potent antineoplastic metabolite for potential differentiation therapy for CRC patients.

2020-03-23 | GSE140269 | GEO

α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer [RNA-seq II]

2020-03-23 | GSE140267 | GEO

α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer [RNA-seq I]

2020-03-23 | GSE140266 | GEO